Customer Center
Login | Register

Investor Relations

  • Banner Image

News Releases

Date Title  
Toggle Summary Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio
AUSTIN, Texas , Jan. 2, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases.